New alternative phosphorylation sites on the cyclin dependent kinase 1/cyclin a complex in p53-deficient human cells treated with etoposide: Possible association with etoposide-induced apoptosis

Apoptosis

Volumn 12, Issue 10, 2007, Pages 1847-1855

  Higginbottom, Karen ^a   Jahnke, Ulrike ^a   Newland, Adrian C ^a   Cotter, Finbarr E ^a   Allen, Paul David ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Apoptosis; Cdk1; Cyclin A; Cyclin B; Mitotic catastrophe

Indexed keywords

CYCLIN A; CYCLIN B; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; ETOPOSIDE; PROTEIN P53; TYROSINE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL DEATH; COMPUTER ANALYSIS; CONTROLLED STUDY; DNA DAMAGE; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOSIS; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CDC2 PROTEIN KINASE; CELL CYCLE; CYCLIN A; CYCLIN B; ETOPOSIDE; HL-60 CELLS; HUMANS; K562 CELLS; MULTIPROTEIN COMPLEXES; PHOSPHORYLATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34848918885     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-007-0104-6     Document Type: Article

References (29)

1. Ding J, Miao ZH, Meng LH, Geng MY (2006) Emerging cancer therapeutic opportunities target DNA-repair systems. Trends Pharmacol Sci 27:338-344
2. Harris SL, Levine AJ (2005) The p53 pathway: positive and negative feedback loops. Oncogene 24:2899-2908
3. Sidransky D, Hollstein M (1996) Clinical implications of the p53 gene. Ann Rev Med 47:285-301
4. Chen GL, Yang L, Rowe TC, Halligan BD, Tewey KM, Liu LF (1984) Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J Biol Chem 259:13560-13566
5. Lock RB, Ross WE (1990) Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese Hampster Ovary cells. Cancer Res 50:3761-3766
6. Borgne A, Versteege I, Mahe M et al (2006) Analysis of cyclin B1 and CDK activity during apoptosis induced by camptothecin treatment. Oncogene 25:7361-7372
7. Castedo M, Roumier T, Blanco J et al (2002) Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV-1 envelope. EMBO J 21:4070-4080
8. Martins LM, Kottke TJ, Kaufmann SH, Earnshaw WC (1978) Phosphorylated forms of activated caspases are present in cytosol from HL-60 cells during etoposide-induced apoptosis. Blood 92:3042-3049
9. Martins LM, Mesner PW, Kottke TJ et al (1997) Comparison of caspase activation and subcellular localisation in HL-60 and K562 cells undergoing etoposide-induced apoptosis. Blood 90:4283-4296
10. Lin C-F, Chen C-L, Chang W-T et al (2005) Bcl-2 rescues ceramide and etoposide induced mitochondrial apoptosis through blockage of caspase 2 activation. J Biol Chem 280:23758-23765
11. Lock RB, Stribinskiene L (1996) Dual modes of death induced by etoposide in human epithelial tumour cells a low Bcl-2 to inhibit apoptosis without affecting clonogenic survival. Cancer Res 56:4006-4012
12. Roninson IB, Broude EV, Chang B-D (2001) If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat 4:303-313
13. Nurse P (1990) Universal control mechanism regulating onset of M-phase. Nature 344:503-508
14. Morgan DO (1995) Principles of CDK regulation. Nature 374:131-134
15. Parker LL, Piwnica-Worms H (1992) Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase. Science 257:1955-1957
16. Mueller PR, Coleman TR, Kumagai A, Dunphy WG (1995) Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine 14 and tyrosine 15. Science 270:86-90
17. Jackman M, Lindon C, Nigg EA, Pines J (2003) Active cyclin B1-Cdk1 first appears on centrosomes in prophase. Nat Cell Biol 5:143-148
18. McGowan CH, Russell P (2004) The DNA damage response: sensing and signalling. Curr Opin Cell Biol 16:629-633
19. Jin P, Hardy S, Morgan DO (1998) Nuclear localisation of cyclin B1 controls mitotic entry after DNA damage. J Cell Biol 141:875-885
20. Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B (1999) 14-3-3 sigma is required to prevent mitotic catastrophe after DNA damage. Nature 401:616-620
21. Wolf D, Rotter V (1985) Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc Natl Acad Sci U S A 82:790-794
22. Bi S, Hughes T, Bungey J, Chase A, de Fabritiis P, Goldman JM (1992) p53 in chronic myeloid leukemia cell lines. Leukemia 8:839-842
23. Darzynkiewicz Z, Bruno S, Del Bino G et al (1992) Features of apoptotic cells measured by flow cytometry. Cytometry 13:795-808
24. McGahon A, Bissonnette R, Schmitt M, Cotter KM, Green DR, Cotter TG (1994) BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood 83:1179-1187
25. Boutros R, Dozier C, Ducommun B (2006) The when and wheres of CDC25 phosphatases. Curr Opin Cell Biol 18:185-191
26. Blom N, Gammeltoft S, Brunak S (1999) Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 294:1351-1362
27. Cavalli A, Dezi C, Folkers G, Scapozza L, Recanatini M (2001) Three-dimensional model of the cyclin-dependent kinase 1 (CDK1): ab initio active site parameters for molecular dynamics studies of CDKS. Proteins 45:478-485
28. De Bondt HL, Rosenblatt J, Jancarik J, Jones HD, Morgan DO, Kim SH (1993) Crystal structure of cyclin-dependent kinase 2. Nature 363:595-602
29. Jeffrey PD, Russo AA, Polyak K et al (1995) Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 376:313-320